Lambert-Eaton Syndrome, an Unrecognized Treatable Pediatric Neuromuscular Disorder: Three Patients and Literature ReviewContents lists avai Lambert-Eaton Syndrome, an Unrecognized

CLINICAL GUIDELINE A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the

()LambertLambertLambertLambert----Eaton MyasthenicEaton MyasthenicEaton MyasthenicEaton Myasthenic Syndrome Syndrome Syndrome Syndrome David E Stickler, MD, Assistant Professor,

Reference: NHS England: 16009/P Directorate Finance further information Document Status This is a controlled document.  Whilst this document may be printed, the electronic

DOI: 10.1159/000494078 Published online: December 5, 2018 © 2018 The Author(s) Published by S. Karger AG, Basel www.karger.com/crn This article is licensed under the

Get to know this rare neuromuscular disorder with a devastating impact LEMS symptoms are insidious and progressive, characteristically beginning with5,6: • Lower limb

mg.pdfLAMBERT-EATON MYASTHENIC SYNDROME: Developed by the AAEM Quality Assurance Committee (1997-2000): primary authors: Faye Y. Chiou- Tan, MD; Richard W. Tim, MD; and James

Lambert-Eaton Myasthenic Syndrome: A ReviewHideyuki Matsumoto, MD, PhD1 and Yoshikazu Ugawa, MD, PhD2 1 Department of Neurology, Japanese Red Cross Medical Center, Tokyo,

Microsoft Word - MG COVID19 guidelines.docxGuidance for the management of Myasthenia Gravis (MG) and Lambert-Eaton Myasthenic Syndrome (LEMS) during the COVID- 19 pandemic

INTRODUCTION The approach to patients with neuromuscular disorders is chal- lenging. As in other neurological diseases the key to arriving at the correct diagnosis is careful